Scheme will invest across large-cap, mid-cap and small-cap shares, says company
Headline valuations are at 10-15 per cent premium to 10-year historical range, but are supported by the lower bond yields in comparison to what we have witnessed in the last decade, Singh said
Rate hikes will be something which we can expect when the borrowing programme comes down and economic growth prospects are strong, Nagarjan said
In a Q&A, the CIO-Equities of the fund house says the movement of the dollar and global crude prices will be key factors to watch out for going ahead
According to data from Bloomberg, banks have seen among the sharpest cuts in target prices -- between 16 and 60 per cent.
The next hearing on the matter is expected to be held in the second week of November
The Indian pharma sector has many attractive opportunities before it, such as the growing adoption of generic drugs in developed markets
Lack of a stable leadership has made it difficult for Tata MF to gain sizable market share